News
WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback